Cajeta, Arian .
HRN: 22-34-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
CEFTRIAXONE 1G (VIAL)
12/23/2022
12/29/2022
IVT
680mg
Q12
Periapical Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes